Mountain Pacific Investment Advisers’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $20.5M | Sell |
|
|||||
|
2024
Q4 | $25.6M | Sell |
|
|||||
|
2024
Q3 | $27.4M | Sell |
|
|||||
|
2024
Q2 | $29.4M | Sell |
|
|||||
|
2024
Q1 | $39M | Buy |
|
|||||
|
2023
Q4 | $33.8M | Buy |
|
|||||
|
2023
Q3 | $26.1M | Buy |
|
|||||
|
2023
Q2 | $26.1M | Buy |
|
|||||
|
2023
Q1 | $22.1M | Buy |
|
|||||
|
2022
Q4 | $23.3M | Buy |
|
|||||
|
2022
Q3 | $17.7M | Buy |
|
|||||
|
2022
Q2 | $15.8M | Buy |
|
|||||
|
2022
Q1 | $20.9M | Buy |
|
|||||
|
2021
Q4 | $27.4M | Buy |
|
|||||
|
2021
Q3 | $29.2M | Buy |
|
|||||
|
2021
Q2 | $26.2M | Buy |
|
|||||
|
2021
Q1 | $20.5M | Buy |
|
|||||
|
2020
Q4 | $16.4M | Buy |
|
|||||
|
2020
Q3 | $14.8M | Buy |
|
|||||
|
2020
Q2 | $11.4M | Buy |
|
|||||
|
2020
Q1 | $998K | Buy |
|
|||||
|
2019
Q4 | $1.02M | Sell |
|
|||||
|
2019
Q3 | $959K | Sell |
|
|||||
|
2019
Q2 | $1.03M | Sell |
|
|||||
|
2019
Q1 | $1.06M | Buy |
|
|||||
|
2018
Q4 | $812K | Buy |
|
|||||
|
2018
Q3 | $567K | Hold |
|
|||||
|
2018
Q2 | $473K | Buy |
|